CCL23 Inhibitors

CCL23 inhibitors include an array of compounds primarily focused on disrupting chemokine-receptor interactions and the subsequent intracellular signaling pathways. Compounds like Maraviroc, TAK-779 are direct antagonists of the CCR5 receptor, which can intercept and prevent the actions of chemokines that rely on this receptor for signaling.

The inhibition of other chemokine receptors, such as CCR1, CCR2, CCR3, and CXCR4, with compounds like AZD-5672, UCB35625, and AMD3100, can provide indirect modulation of CCL23 function. Apart from receptor antagonism, some compounds like Rapamycin target broader cellular pathways like mTOR signaling, which plays a pivotal role in immune cell function and might intersect with CCL23-mediated events. The diverse nature of these inhibitors, from chemokine analogs like Met-RANTES to broad-spectrum agents like Rapamycin.